logo
light
search

ERLVX Holdings List NMFQS:ERLVX

Large Value | Eaton Vance
$31.73
↓ $-0.09 (-0.28%)
Last Updated: Oct 20, 2026

Eaton Vance Large-Cap Value R6 (ERLVX) - Large Value fund with $2.03 Billion in assets. The fund allocates 18.26% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.

The largest holding in the fund is Charles Schwab Corp/The at 2.67% of total assets. This is followed by Chevron Corp (None) and NextEra Energy Inc (2.66%).

ERLVX Holdings

Name Weight Owned Change
Charles Schwab Corp/The 2.67% - -
Chevron Corp None - -
NextEra Energy Inc 2.66% - -
Micron Technology Inc 2.51% - -
Thermo Fisher Scientific Inc 3.01% - -
Reinsurance Group of America Inc 2.47% - -
Wells Fargo Co 2.57% - -
Hasbro Inc None - -
Mid-America Apartment Communities Inc None - -
3M Co 2.37% - -
AbbVie Inc 2.65% - -
Bristol-Myers Squibb Co 2.29% - -
American International Group Inc 2.28% - -
Johnson Controls International plc 2.22% - -
Cisco Systems Inc 2.81% - -
Morgan Stanley Institutional Liquidity Funds - Government Portfolio 2.25% - -
Exxon Mobil Corp 3.18% - -
McDonald's Corp 2.61% - -
Walt Disney Co/The 2.54% - -
Abbott Laboratories 2.58% - -
Bank of America Corp 2.52% - -
Amazon.com Inc 7.45% - -
Meta Platforms Inc 2.44% - -
CSX Corp 2.25% - -
Alphabet Inc 2.89% - -
ConocoPhillips 2.40% - -
Apple Inc 3.34% - -
Merck Co Inc 2.61% - -
Intel Corp 2.39% - -
United Parcel Service Inc 2.33% - -

Asset Allocation

Bond 0.00%
Cash 0.70%
Non US Stock 0.00%
Not Classified 0.00%
Other 0.00%
US Stock 99.30%

Market Cap

AverageMarketCap 152781.30%
Giant 15.23%
Large 39.45%
Medium 38.71%
Micro 0.00%
Small 5.91%

Sector Weights

Cash and Equivalents 4.12%
Corporate 4.12%
Derivative 4.12%
Government 4.12%
Municipal 4.12%
Securitized 4.12%
Basic Materials 3.90%
Consumer Cyclical 14.49%
Financial Services 16.94%
Real Estate 1.42%
Consumer Defensive 6.80%
Healthcare 13.52%
Utilities 4.12%
Communication Services 1.95%
Energy 8.98%
Industrials 12.84%
Technology 15.03%

World Regions

Latin America 0.00%
North America 100.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Australasia 0.00%
Japan 0.00%
Africa/Middle East 0.00%
Europe Developed 0.00%
Europe Emerging 0.00%
United Kingdom 0.00%